Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 25,000 shares at $1.75 ($44K) on 2008-11-03, disclosed to the SEC on 2008-11-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.74 | 2,100 | $4K | 8.4% |
| 2 | $1.75 | 22,900 | $40K | 91.6% |
| Total | $1.75 avg | 25,000 | $44K | 100% |
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |